MPX has moved early on “Swipe,” locking down world sales rights to the indie horror film just before the Cannes market opens its doors.

The deal puts Motion Picture Exchange in position to introduce the film to international buyers at the Marché du Film, where horror routinely punches above its weight. Reports indicate MPX sees “Swipe” as a commercially potent genre title, built around a female-driven premise and a stark, unsettling setup: a murderous family of sadistic mute women. In a market crowded with attention-grabbing concepts, that logline lands fast.

“Swipe” marks the second feature from actor-director Sean Whalen, whose career has long stretched beyond directing. That matters in a sales environment where familiarity can help a smaller title cut through the noise. But the real test now shifts from announcement to execution. Cannes buyers do not just want a clever hook; they want a film that can travel across territories, marketing campaigns, and late-night festival buzz.

Horror remains one of the most reliable lanes for indie film sales, and “Swipe” now enters Cannes with a distributor betting that its premise can travel.

Key Facts

  • MPX has acquired world sales rights to the U.S. indie horror film “Swipe.”
  • The film is directed by Sean Whalen and represents his second feature.
  • MPX plans to present “Swipe” to buyers at the upcoming Cannes Marché du Film.
  • The film centers on a murderous family of sadistic mute women.

The timing tells its own story. Cannes remains one of the most important pressure points in the global film business, especially for independent genre projects that need foreign deals to build momentum. Sources suggest MPX aims to position “Swipe” as the kind of horror title that can cut through quickly: distinctive, easy to pitch, and tuned to audience appetite for high-concept fear. That does not guarantee a breakout, but it gives the film a real shot at meaningful international traction.

What happens next will determine whether “Swipe” becomes another market title or a genuine indie horror contender. Buyer response at Cannes will shape its path, from territorial sales to festival visibility and eventual release strategy. For MPX, the bet reflects a broader truth about the business right now: when attention splinters and budgets tighten, horror still offers one of the clearest ways to turn a sharp idea into global momentum.